ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in ARS Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 184
- +20 vs. Q4 2024
- Shares held
- 76.2M
- +6.02M (+8.6%) vs. Q4 2024
- Total value
- $958.9M
- +$218.2M (+29.5%) vs. Q4 2024
- New holders
- 41
- 58 more added
- Sold out
- 21
- 54 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SPRY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 208 | $726.0M |
| Q1 2026 | 203 | $757.5M |
| Q4 2025 | 191 | $1.05B |
| Q3 2025 | 188 | $840.4M |
| Q2 2025 | 188 | $1.48B |
| Q1 2025 | 184 | $958.9M |
| Q4 2024 | 166 | $752.3M |
| Q3 2024 | 151 | $928.4M |
| Q2 2024 | 115 | $533.0M |
| Q1 2024 | 113 | $612.1M |
| Q4 2023 | 100 | $358.5M |
| Q3 2023 | 97 | $251.6M |
| Q2 2023 | 92 | $369.0M |
| Q1 2023 | 90 | $347.7M |
| Q4 2022 | 73 | $427.9M |
| Q3 2022 | 61 | $160.4M |
| Q2 2022 | 64 | $110.5M |
| Q1 2022 | 70 | $94.7M |
| Q4 2021 | 72 | $200.5M |
| Q3 2021 | 74 | $288.4M |
| Q2 2021 | 76 | $864.6M |
| Q1 2021 | 68 | $1.21B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding ARS Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −4,028−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −473−100.0% | Sold out |
| Aspect Partners, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Nextech Invest AG | – | – | – | – | Not filed |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |